Chiang concluded that longer-term studies are needed to clarify potential risks or benefits associated with GLP-1 receptor agonists, adding that his team will continue to monitor emerging data from both RCTs and observational studies.
Perhaps unprecedented in sport, the clamor for more stringent drug policies in track is loudest from the athletesand not only because of the damage to the sports image
Also, monitor for side effects like nausea, constipation, diarrhea, or bloating
The older, sympathomimetic medications, like phentermine, were only approved for short-term use, though many clinicians experienced in obesity care use them for longer than 12 weeks
While the results will be more modest, some support is better than none for people genuinely struggling with appetite regulation
Speak with a qualified healthcare provider before starting a protocol